Controlling Chronic Diseases and Acute Infections with Vitamin D Sufficiency.
Study Goal
The researchers aimed to determine the role of vitamin D in preventing and mitigating chronic diseases and infections, and its broader physiological benefits.
Results Summary
The study found that maintaining vitamin D sufficiency (serum 25(OH)D above 40 ng/mL) improves immune function, reduces chronic disease burden, infections, hospitalizations, and all-cause mortality. It also controls inflammation, oxidative stress, and generates antimicrobial peptides.
Population
Vulnerable communities, including ethnic minorities in temperate countries, older people, those with co-morbidities, night workers, and institutionalized persons.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
proper doses of vitamin D supplementation and/or safe daily sun exposure | decrease | vitamin D deficiency | - | - | can be eliminated | #1 |
maintaining the population serum 25(OH)D concentration above 40 ng/mL (i.e., sufficiency) | increase | a sound immune system | population | - | ensures | #2 |
maintaining the population serum 25(OH)D concentration above 40 ng/mL (i.e., sufficiency) | decrease | symptomatic diseases | population | - | minimizing | #3 |
maintaining the population serum 25(OH)D concentration above 40 ng/mL (i.e., sufficiency) | decrease | infections | population | - | reducing | #4 |
maintaining the population serum 25(OH)D concentration above 40 ng/mL (i.e., sufficiency) | decrease | the prevalence of chronic diseases | population | - | reducing | #5 |
maintaining vitamin D sufficiency | decrease | infections | - | - | reduces | #6 |
maintaining vitamin D sufficiency | decrease | associated complications and deaths | - | - | reduces | #7 |
maintaining vitamin D sufficiency | decrease | chronic disease burden | - | - | reduces | #8 |
maintaining vitamin D sufficiency | decrease | illnesses | - | - | reduces | #9 |
maintaining vitamin D sufficiency | decrease | hospitalizations | - | - | reduces | #10 |
maintaining vitamin D sufficiency | decrease | all-cause mortality | - | - | reduces | #11 |
vitamin D and targeted micronutrient supplementation | neutral | - | vulnerable communities, such as ethnic minorities living in temperate countries, older people, those with co-morbidities, routine night workers, and institutionalized persons | - | would significantly benefit | #12 |
this economical, non-prescription, safe micronutrient | decrease | acute and chronic diseases | - | - | prevent and treat | #13 |
this approach | decrease | morbidity | - | - | will significantly reduce | #14 |
this approach | decrease | mortality | - | - | will significantly reduce | #15 |
this approach | decrease | healthcare costs | - | - | will significantly reduce | #16 |
Apart from developmental disabilities, the prevalence of chronic diseases increases with age especially in those with co-morbidities: vitamin D deficiency plays a major role in it. Whether vitamin D deficiency initiates and/or aggravates chronic diseases or vice versa is unclear. It adversely affects all body systems but can be eliminated using proper doses of vitamin D supplementation and/or safe daily sun exposure. Maintaining the population serum 25(OH)D concentration above 40 ng/mL (i.e., sufficiency) ensures a sound immune system, minimizing symptomatic diseases and reducing infections and the prevalence of chronic diseases. This is the most cost-effective way to keep a population healthy and reduce healthcare costs. Vitamin D facilitates physiological functions, overcoming pathologies such as chronic inflammation and oxidative stress and maintaining broader immune functions. These are vital to overcoming chronic diseases and infections. Therefore, in addition to following essential public health and nutritional guidance, maintaining vitamin D sufficiency should be an integral part of better health, preventing acute and chronic diseases and minimize their complications. Those with severe vitamin D deficiency have the highest burdens of co-morbidities and are more vulnerable to developing complications and untimely deaths. Vitamin D adequacy improves innate and adaptive immune systems. It controls excessive inflammation and oxidative stress, generates antimicrobial peptides, and neutralizes antibodies via immune cells. Consequently, vitamin D sufficiency reduces infections and associated complications and deaths. Maintaining vitamin D sufficiency reduces chronic disease burden, illnesses, hospitalizations, and all-cause mortality. Vulnerable communities, such as ethnic minorities living in temperate countries, older people, those with co-morbidities, routine night workers, and institutionalized persons, have the highest prevalence of vitamin D deficiency-they would significantly benefit from vitamin D and targeted micronutrient supplementation. At least now, health departments, authorities, and health insurance companies should start assessing, prioritizing, and encouraging this economical, non-prescription, safe micronutrient to prevent and treat acute and chronic diseases. This approach will significantly reduce morbidity, mortality, and healthcare costs and ensure healthy aging.